FI944550A - Cis-elementer av oljekavitetsproteiner som regulatorsignaler - Google Patents

Cis-elementer av oljekavitetsproteiner som regulatorsignaler Download PDF

Info

Publication number
FI944550A
FI944550A FI944550A FI944550A FI944550A FI 944550 A FI944550 A FI 944550A FI 944550 A FI944550 A FI 944550A FI 944550 A FI944550 A FI 944550A FI 944550 A FI944550 A FI 944550A
Authority
FI
Finland
Prior art keywords
pct
oil cavity
cis elements
proteins
constructs
Prior art date
Application number
FI944550A
Other languages
English (en)
Finnish (fi)
Other versions
FI120314B (sv
FI944550A0 (sv
Inventor
Maurice M Moloney
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA1992/000161 external-priority patent/WO1993021320A1/en
Priority claimed from PCT/CA1993/000141 external-priority patent/WO1993020216A1/en
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Publication of FI944550A0 publication Critical patent/FI944550A0/sv
Publication of FI944550A publication Critical patent/FI944550A/sv
Application granted granted Critical
Publication of FI120314B publication Critical patent/FI120314B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8234—Seed-specific, e.g. embryo, endosperm
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
FI944550A 1992-04-02 1994-09-30 Oljekavitetsprotein-cis-elementer som regleringssignaler FI120314B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US86235592A 1992-04-02 1992-04-02
US86235592 1992-04-02
PCT/CA1992/000161 WO1993021320A1 (en) 1991-02-22 1992-04-15 Oil-body proteins as carriers of high-value peptides in plants
CA9200161 1992-04-15
PCT/CA1993/000141 WO1993020216A1 (en) 1991-02-22 1993-04-02 Oil-body protein cis-elements as regulatory signals
CA9300141 1993-04-02

Publications (3)

Publication Number Publication Date
FI944550A0 FI944550A0 (sv) 1994-09-30
FI944550A true FI944550A (sv) 1994-11-30
FI120314B FI120314B (sv) 2009-09-15

Family

ID=25683013

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944550A FI120314B (sv) 1992-04-02 1994-09-30 Oljekavitetsprotein-cis-elementer som regleringssignaler

Country Status (12)

Country Link
US (1) US5792922A (sv)
EP (1) EP0633940B1 (sv)
JP (1) JP3660354B2 (sv)
KR (1) KR100278456B1 (sv)
AT (1) ATE229076T1 (sv)
AU (1) AU678154B2 (sv)
DE (1) DE69332538T2 (sv)
ES (1) ES2187505T3 (sv)
FI (1) FI120314B (sv)
NO (1) NO321501B1 (sv)
RU (1) RU2148647C1 (sv)
UA (1) UA41319C2 (sv)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586661B1 (en) * 1997-06-12 2003-07-01 North Carolina State University Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid
US6635806B1 (en) * 1998-05-14 2003-10-21 Dekalb Genetics Corporation Methods and compositions for expression of transgenes in plants
DE19923571A1 (de) * 1999-05-21 2000-11-23 Kws Saat Ag Nukleotid-Sequenz zur Erhöhung der Abwehrreaktion einer Pflanze gegen Pathogenbefall
US20030140372A1 (en) * 1999-06-07 2003-07-24 Shen Jennie Bih-Jien Genes for desaturases to alter lipid profiles in corn
US6784342B1 (en) 1999-08-04 2004-08-31 The University Of British Columbia Regulation of embryonic transcription in plants
RU2164944C1 (ru) * 1999-12-09 2001-04-10 Институт молекулярной биологии им. В.А. Энгельгардта РАН Способ изменения генетических свойств организма
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
EP1349946B1 (en) 2000-08-25 2011-01-26 BASF Plant Science GmbH Plant polynucleotides encoding prenyl proteases
ATE333506T1 (de) * 2000-08-30 2006-08-15 Univ North Carolina State Transgene pflanzen, die molekulare decoys enthalten, die den proteininhalt ändern
US20090197337A1 (en) * 2000-12-19 2009-08-06 Van Rooijen Gijs Methods for the production of multimeric proteins and related compositions
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
MXPA03009627A (es) 2001-04-24 2004-01-29 Cornell Res Foundation Inc MOLECULA SINTETICA DE ACIDO NUCLEICO PARA IMPARTIR CARACTERiSTICAS MULTIPLES.
NZ529597A (en) 2001-05-30 2005-12-23 Chromos Molecular Systems Inc Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
EP2322229B1 (en) 2001-10-10 2016-12-21 Novo Nordisk A/S Remodeling and glycoconjugation of Factor IX
WO2003031464A2 (en) 2001-10-10 2003-04-17 Neose Technologies, Inc. Remodeling and glycoconjugation of peptides
US7329798B2 (en) * 2002-06-28 2008-02-12 University Of Guelph Harvest-inducible regulatory elements and methods of using same
AU2003245772A1 (en) 2002-06-28 2004-01-19 University Of Guelph Harvest-inducible genes form alfalfa (medicago sativa) and methods of use thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
CA2515481A1 (en) 2003-02-14 2004-09-02 Biogen Idec Ma Inc. An expression cassette and vector for transient or stable expression of exogenous molecules
SG155777A1 (en) 2003-04-09 2009-10-29 Neose Technologies Inc Glycopegylation methods and proteins/peptides produced by the methods
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
AR044803A1 (es) 2003-06-17 2005-10-05 Sembiosys Genetics Inc Metodos para la produccion de insulina
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2005041151A2 (en) * 2003-10-02 2005-05-06 Vector Tobacco Ltd. Tobacco product labeling system
CA2609953A1 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
CA2609367C (en) 2005-05-23 2014-08-19 Arcadia Biosciences, Inc. Safflower with elevated gamma-linolenic acid
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090049569A1 (en) * 2007-08-13 2009-02-19 Pioneer Hi-Bred International, Inc. Seed-Preferred Regulatory Elements
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
AU2009252377B2 (en) * 2008-05-28 2014-01-23 Kyoto University Novel selection marker gene and use thereof
RU2561463C2 (ru) 2009-04-22 2015-08-27 Басф Плант Сайенс Компани Гмбх Промотор целого семени
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2776366C (en) 2009-10-02 2017-07-18 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221259A (en) * 1986-07-31 1990-05-28 Calgene Inc Seed specific transcriptional regulation
EP0667906A1 (en) * 1991-11-15 1995-08-23 E.I. Du Pont De Nemours And Company $g(b)-KETOACYL-ACP SYNTHETASE II GENES FROM PLANTS

Also Published As

Publication number Publication date
DE69332538T2 (de) 2003-11-06
NO943664D0 (no) 1994-09-30
RU2148647C1 (ru) 2000-05-10
EP0633940B1 (en) 2002-12-04
UA41319C2 (uk) 2001-09-17
ES2187505T3 (es) 2003-06-16
NO321501B1 (no) 2006-05-15
FI120314B (sv) 2009-09-15
AU678154B2 (en) 1997-05-22
RU94046161A (ru) 1997-05-10
JP3660354B2 (ja) 2005-06-15
DE69332538D1 (de) 2003-01-16
NO943664L (no) 1994-11-15
EP0633940A1 (en) 1995-01-18
KR950700995A (ko) 1995-02-20
JPH07505525A (ja) 1995-06-22
US5792922A (en) 1998-08-11
ATE229076T1 (de) 2002-12-15
AU3884493A (en) 1993-11-08
KR100278456B1 (ko) 2001-01-15
FI944550A0 (sv) 1994-09-30

Similar Documents

Publication Publication Date Title
FI944550A (sv) Cis-elementer av oljekavitetsproteiner som regulatorsignaler
EA200000926A1 (ru) Экспрессия генов биосинтеза трегалозы в растениях
DE69115280T2 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
ATE210180T1 (de) Xylanase beinhaltende futterzusätze für tiere
ATE151462T1 (de) Modifiziertes baculovirus, verfahren zu seiner herstellung, und dessen expressionsvektoren
NO950534L (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
NO930011D0 (no) Tilfeldig boi-oligomer bibilotek og fremgangsmaate for syntese og anvendelse derav
EA200000109A1 (ru) Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения
DE69632546D1 (de) Ob proteinderivate mit verlängerter halbwertzeit
WO1998035020A3 (en) Methods for modulating hematopoiesis and vascular growth
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
ATE356878T1 (de) Herstellung von proteinen in eiern
KR950700234A (ko) β-페닐이소세린 및 그외 동족체를 제조하는 방법(Method for preparing β-phenylisoserine and analogues thereof)
DK0914419T3 (da) Transgene mus i stand til at udtrykke leukæmiinhiberende faktor
EA199900261A1 (ru) Генная терапия застойной сердечной недостаточности
DE69734644D1 (de) Carboxypeptidasen aus aspergillus oryzae und diese kodierende nukleinsäuren
FR2703054B1 (fr) Promoteur vegetal inductible au stress et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur.
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN
ATE317021T1 (de) Antisense modulierung von lfa-3
WO1998024887A3 (en) Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
DE69829953D1 (de) Kristallisation von proteinen
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
ATE317020T1 (de) Neues regulationssystem zur kontrolle der expression eines transgens
CA2133417A1 (en) Oil-body protein cis-elements as regulatory signals
DE69434072D1 (de) Regulierende nukleinsaeuresequenzen und verwendungen

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SEMBIOSYS GENETICS INC.

FG Patent granted

Ref document number: 120314

Country of ref document: FI

MA Patent expired